共 9 条
[1]
Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Maisel AS,McCord J,Nowak RM,et al. Journal of the American College of Cardiology . 2003
[2]
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Maisel AS,Koon J,Krishnaswamy P,et al. American Heart Journal . 2001
[3]
Biochemical detection of left-ventricular systolic dysfunction. McDonagh TA,Robb SD,Murdoch DR,et al. The Lancet . 1998
[4]
Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Murdoch DR,McDonagh TA,Byrne J,et al. American Heart Journal . 1999
[5]
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP)concentrations. Troughton RW,Frampton CM,Yandle TG,et al. The Lancet . 2000
[6]
Plasma N-terminal probrain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction.Australia-New Zealand Heart Failure Group. Richards AM,Doughty R,Nicholls MG,et al. Journal of the American College of Cardiology . 2001
[7]
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure. Cheng V,Kazanagra R,Garcia A,et al. Journal of the American College of Cardiology . 2001
[8]
Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Lubien E,DeMaria A,Krishnaswamy P,et al. Circulation . 2002
[9]
The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Villacorta H,Duarte A,Duarte NM,et al. Arquivos Brasileiros de Cardiologia . 2002